3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
3
OTHER_GOV
1
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
1
Kidney Neoplasms
1
Hematuria
1
Carcinoma, Transitional Cell
1
Interventions
Capecitabine
9
Bevacizumab
8
tislelizumab
7
Oxaliplatin
7
Drug Therapy
7
pembrolizumab
6
Surgical Procedures, Operative
6
Standard of Care
6
Cisplatin
6
Radiotherapy
5
Laparoscopy
5
Fluorouracil
5
Docetaxel
5
Carboplatin
5
Radiosurgery
4
Leucovorin
4
Exercise
4
Epirubicin
4
Cyclophosphamide
4
toripalimab
3
pertuzumab
3
durvalumab
3
dalpiciclib
3
atezolizumab
3
anlotinib
3
Saline Solution
3
Rituximab
3
Prednisone
3
Population Groups
3
Observation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Cytological Techniques
×
1 year
×
Clear all
NCT07037589
2025-11-21
BLUSH
Vastra Gotaland Region
Recruiting
300 enrolled